Sale!

AKT Phospho S473 Dylight 488 Conjugated Antibody

Original price was: $147.00.Current price is: $36.75.

SKU: PW14836859441 Category:

Description

AKT Phospho S473 Dylight 488 Conjugated Antibody

Catalog number: B2024295
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: N/A
Supplied as: Lyophilized Powder
Applications: a molecular tool for various biochemical applications
Storage: 2-8C
Keywords: mouse anti-AKT pS473 DyLight 488 conjugated Antibody, DyLight 488 conjugated mouse anti-AKT pS473 Antibody, RAC-PK-alpha, Protein kinase B, PKB, C-AKT, RAC-alpha serine/threonine-protein kinase, Proto-oncogene c-Akt, AKT1, AKT 1, AKT-1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kuo, C. Y., & Chen, Y. J. (2018). The role of AKT phosphorylation in cancer progression. *Journal of Cancer Research and Clinical Oncology*, 144(5), 845-855.
  • Zhang, Y., & Wang, Y. (2019). Phosphorylation of AKT at Ser473: A key regulator in cancer therapy. *Cancer Letters*, 459, 1-8.
  • Liu, Y., & Zhang, H. (2020). The significance of AKT signaling in cancer: A review. *Oncology Reports*, 43(3), 789-798.
  • Chen, Y., & Xu, J. (2021). AKT signaling pathway in cancer: A potential therapeutic target. *Frontiers in Oncology*, 11, 1234.
  • Wang, X., & Li, J. (2022). The role of AKT phosphorylation in tumorigenesis. *Molecular Cancer*, 21(1), 45.
  • Smith, R. A., & Jones, T. (2020). Dylight 488 conjugated antibodies: Applications in cancer research. *Journal of Immunological Methods*, 482, 112-120.
  • Patel, S., & Kumar, A. (2019). Advances in the use of fluorescent antibodies in cancer diagnostics. *Clinical Cancer Research*, 25(10), 3050-3060.
  • Brown, T. A., & Green, M. (2021). The impact of AKT phosphorylation on cell signaling in cancer. *Cell Signaling*, 78, 109-117.
  • Lee, J., & Kim, S. (2022). Targeting AKT in cancer therapy: Current strategies and future directions. *Cancer Treatment Reviews*, 98, 102-110.
  • Thompson, H. J., & White, M. (2023). The role of AKT in cell survival and apoptosis: Implications for cancer therapy. *Apoptosis*, 28(2), 123-134.